CureVac Launches IPO, Adds To Big 2020 Cash Haul

 
• By Mandy Jackson

CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.

Well-dressed man standing in a big room in front of big silver dollar sign with blue sky inside it. Symbol of power, money and freedom. Targeting success and happiness. Back view.
Its mRNA vaccine against SARS-CoV-2 put CureVac in the stock market spotlight • Source: Shutterstock

More from Financing

More from Business